Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
This report contains market size and forecasts of Liquid Biopsy Products in Global, including the following market information:
Global Liquid Biopsy Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liquid Biopsy Products market was valued at 1763.6 million in 2021 and is projected to reach US$ 8132.7 million by 2028, at a CAGR of 24.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CTCs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid Biopsy Products include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics and Cynvenio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liquid Biopsy Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Biopsy Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liquid Biopsy Products Market Segment Percentages, by Type, 2021 (%)
CTCs
ctDNA
Exosomes
Global Liquid Biopsy Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liquid Biopsy Products Market Segment Percentages, by Application, 2021 (%)
Blood Sample
Urine Sample
Other Bio Fluids
Global Liquid Biopsy Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liquid Biopsy Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Biopsy Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liquid Biopsy Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc